Small plasmids which replicate in both Escherichia coli and Clostridium perfringens were made by recombining E. coli plasmid pBR322 with three different small (less than 4 kilobases) plasmids native to C. perfringens. Subsequently, two homologous, though distinct, tetracycline resistance determinants (tet) from other C. perfringens plasmids were cloned into them. Both tet systems made E. coli resistant to at least 5 ,g of tetracycline per ml when resident on the shuttle plasmids. The shuttle vectors have been used to transform Lphase variants and autoplasts of C. perfringens. In the latter case, the intact transforming plasmid could be isolated from walled cells after cell wall regeneration. Reciprocal transformation experiments in which plasmid DNAs derived from E. coli or C. perfringens were used suggest that restriction barriers exist between these two organisms. The plasmids contain restriction enzyme recognition sites in locations which are useful for cloning experiments.
In the accompanying paper (6), we describe methods for transforming L-phase variants and autoplasts of Clostridium perfringens with plasmid DNA. Although the plasmids we used in those experiments confer tetracycline resistance (Tcr), they are too complex for molecular cloning experiments. In addition, Clostridium plasmid cloning vectors should replicate in and contain selective markers for Escherichia coli, in which genetic and biochemical experiments of greater sophistication can be performed. We have assembled a series of plasmid vectors consisting of plasmid pBR322 from E. coli recombined individually with three distinct cryptic small plasmids isolated from C. perfingens strains.
Further, we added to these vectors the tet genes obtained from C. perfringens plasmids pCW3 (10) and pJU124 described in the preceding paper (6) . These shuttle vectors replicate and persist without selection in both C. perfringens and E. coli. The C. perfringens tet genes function well enough in E. coli to make transformants resistant to tetracycline.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The C. perfringens strains used and their plasmids are listed in Table 1 . E. coli K-12 strains used were HB101 hsdR hsdM recA13 supE44 lacZ4 leuB6 proA2 thi-l rpsL as described by Davis et al. (5) and LS1143 F-recAl ilvA467 metE rbs-215 gal rpsL obtained from Larry Soll (Synergen, Inc., Boulder, Colo.).
The maintenance and growth of C. perfringens strains and liquid and solid media were as described previously (6) . Liquid cultures of E. coli K-12 were grown in Luria broth (5) . This medium was solidified with 1.5% agar for growth on petri plates. These media were supplemented with 25 ,ug of ampicillin per ml and 4 ,ug of tetracycline per ml for selective purposes.
Preparations of plasmid DNA, gel electrophoresis, and construction of recombinant plasmids. Plasmid DNAs from C. perfringens (9) or E. coli (5) were prepared by cesium chloride-ethidium bromide centrifugation of cleared lysates. Agarose gel electrophoresis was done in Tris-borate-EDTA buffer (5) , and extraction of plasmid DNAs from solid * Corresponding author.
agarose was done by methods described by Davis et al. (5) . The restriction endonucleases listed in Table 1 were purchased from New England Biolabs, Beverly, Mass., and used according to the specifications of the manufacturer. Ligation of linear DNA fragments to form recombinant circular molecules was done in a total volume of 25 ULl. We used a fivefold molar excess of the fragment to be inserted (relative to the linearized vehicle). These reactions were incubated at 16°C for ca. twelve h with ca. 1 to 5 U of T4 DNA ligase (New England Biolabs). Potential recombinant clones were identified initially by phenotype (see below), then by whole cell lysis and electrophoresis (1) , and then by plasmid preparation (2), restriction endonuclease digestion, and agarose gel electrophoresis.
Recombinant DNA experiments involving the movement of DNA from C. perfringens to E. coli or vice versa were done with prior approval of the Recombinant DNA Activities Committee of the National Institutes of Health and with P2 containment conditions where required.
DNA-DNA hybridizations. Plasmid DNAs were transferred to nitrocellulose paper by the method of Southern (11) essentially as described by Davis et al. (5) . For the experiment described in Fig. 3 , ca. 1 jig of plasmid DNA was run in each lane. After transfer, ca. 106 cpm of denatured 32p_ labeled (8) DNA probe was hybridized to the bound DNA.
Transformations. Transformations of E. coli K-12 HB101 and LS1143 were done as described by Davis et al. (5) . For the experiment described in Table 3 , 1 ,ug of plasmid DNA was used in each transformation.
Transformation of C. perfringens L-phase variants or autoplasts was done as previously described (6) . However, when plasmid DNA derived from E. coli was used to transform L-phase variants of C. perfringens, the transformed cells were resuspended in 50 ml of brain heart infusion broth (Difco Laboratories, Detroit, Mich.) plus 0.5 M sucrose (BHI-S) medium and incubated at 37°C for 16 to 20 h before plating on selective medium (6) (2 ,ug of tetracycline per ml). Transformation mixtures achieved 10 to 15 doublings during the growth period. Between 1 and 5 ,ug of plasmid DNA is used in transformation of C. perfringens.
Plasmid curing of C. perfringens. Spontaneous loss of plasmids pCW3 (native) and pJU12 (chimeric) from C. perfringens (see Table 4 ) was determined in the following way. Strains (either walled or L-phase variants) containing Table 1) . The smaller plasmids, pJU121, pJU122, and pJU281, were prepared by extracting the DNAs from agarose gels (5) . Plasmids pJU121, pJU122, and pJU281 are each cut at one site by enzymes compatible with the BamHI site of E. coli plasmid pBR322 (3) ( Table 1 ). This site is within the tet gene of pBR322, and insertion destroys its activity (3). Accordingly, plasmids pJU121 and pJU122 were cut with restriction enzyme BglII, and pJU281 was cut with Sau3aI; the products individually ligated to plasmid pBR322 that had been digested with BamHI. The resulting mixtures containing recombinant plasmids were then used to transform E. coli HB101 with selection for ampicillin-resistant (Ampr) clones. Approximately 5% of these were found to be Tcs. Tc' clones were identified as recombinants of pBR322 and C. perfringens plasmids by three criteria: size, restriction enzyme digestion patterns, and DNA-DNA hybridizations.
In the case of the recombinant formed between plasmids pBR322 and pJU281, called pJU1 ( Fig. 1 and 2 ), we expect a plasmid of ca. 6 kilobases (kb), a Sau3aI fragment of 1.6 kb, and one or two BamHI sites formed by the junction of Sau3aI and BamHI. Also, two Hinfl fragments replacing the 1,631-base-pair Hinf fragment of pBR322 should be present. The enzyme digestions of pBR322 and pJU1 shown in lanes 2 through 7 ( Fig. 1 ). shows that a single new 1,600-base-pair Sau3aI fragment has been added to pBR322 to make plasmid pJU1. Insertion into the BamHI site of pBR322 with pJU281, which has one Hinfl site of its own, will replace its 1,631-base-pair Hinfl fragment with two new fragments (cf. lanes 5 and 6 of Fig. 1A ). Finally, in approximately one in four cases, the junction of Sau3aI and BamHI sites will reform a BamHI site. The BamHI-EcoRI double digest of plasmid pJU1 (Fig.  1A , lane 7) shows that there is a single BamHI site in this plasmid 375 base pairs from EcoRI. In summary, these observations yield the restriction map of plasmid pJU1 shown in Fig. 2 . Finally, Fig. 3 shows a DNA-DNA hybridization experiment in which plasmid pJU1 was labeled by nick translation (8) and hybrized to pBR322 (lane 3) and plasmids pJU281, pJU282, pJU283, and pJU284 (lane 1) that had been resolved by agarose gel electrophoresis and bound to a nitrocellulose filter (11) . Note that plasmid pJU1 hybridies specifically to plasmids pJU281 and pBR322 (Fig. 3A) . The above information establishes plasmid pJU1 as a hybrid of plasmids pBR322 and pJU281 and defines its structure.
The identities of plasmids pJU3 (a hybrid of plasmids pBR322 and pJU121) and pJU5 (pBR322 plus pJU122) were determined in much the same way. These plasmids are 7.6 and 8.2 in size, respectively, the sizes predicted by the sums of plasmids pJU121 and pJU122 with pBR322 (Fig. 1B, lanes  2 and 3) . Plasmid pJU121 contains a single HindIll site, and pJU122 contains a unique HincII site ( Table 1 ). The agarose gel (Fig. 1B, lanes 4 , 5, and 6) of enzyme digestions of these plasimds confirms the presence of these sites in pJU3 and pJU5 and gives the restriction maps for the two plasmids shown in Fig. 2 Fig. 4 ; although similar as substrates for EcoRI, they are not identical (cf. lanes 2 and 8). We used these enzymes in an attempt to subclone the Tcr coding sequences of these plasmids to the unique EcoRI and HindIlI sites of plasmid pJU1. The products of ligation were used to transform E. coli HB101 with selection made for Ampr (50 ,ug/ml) Tcr (4 ,ug/ml) clones. In the case of pJU124, Ampr Tcr clones arose in the EcoRI experiment, and in the case of pCW3, they arose in the HindIII experiment. A representative from each experiment was saved, and these plasmids are called pJU7 (pJU1 plus pCW3) and pJU10 (pJU1 plus pJU124), respectively (Fig. 2 ). An agarose gel fractionation of digestions of these plasmids with enzymes EcoRI and Hin-dlIl (pJU7) or EcoRI (pJU10) is shown in Fig.  4 ; plasmid pJU10 contains a 4-kb EcoRI fragment from plasmid pJU124 (cf. lanes 2 and 3) , and plasmid pJU7 contains several HindlIl fragments from plasmid pCW3 (cf. lanes 5 and 6). Multiple HindlIl fragments might be the result of either an incomplete digestion of plasmid pCW3 or the presence of Hindlll sites within the tet gene of pCW3. Besides the fragment size comparisons shown in Fig. 4 , we have also demonstrated by DNA-DNA hybridization that plasmids pJU7 and pJU19 contain DNA sequences homologous to the corresponding HindIll or EcoRI fragments in plasmids pCW3 or pJU124.
These two tet genes were subcloned to plasmids pJU3 and pJU5 (Fig. 2) . The gene from plasmid pCW3 found in pJU7 was cloned to pJU3 and pJU5 via EcoRI digestion and ligation to form recombinant clones. Two EcoRI fragments (ca. 2 kb each) were cloned in these cases (Fig. 2) . The fragments are in the same orientation with respect to one another in both plasmids. That from pJU124 found in plasmid pJU10 was cloned to pJU5 by the same method. These plasmids are called pJU12, pJU13, and pJU16, respectively (see Fig. 2 for partial restriction maps of these plasmids). All of these later plasmids confer a stable Ampr Tcr phenotype on E. coli.
Transformation of C. perfringens L-phase variants with chimeric vectors. The chimeric vectors described in the previous section should replicate in and confer Tcr to both E. coli and C. perfringens. We attempted to transform L-phase variants of C. perfringens with plasmid DNA isolated from E. coli by the procedure described in the previous paper (6) . However, we did not obtain transformants without the addition of an outgrowth step to the transformation protocol. L-phase variants that had been exposed to plasmid DNA and polyethylene glycol were cultutred in B4H1-S medium overnight and then plated with selection for Tcr clones. Plasmid DNA prepared from E. coli will typically transform C. perfringens L-phase varianits at a frequency of 10-8 to (transformants per viable cell per jig of DNA). If the chimeric plasmid DNA was then prepared from the C. perfringens L-phase variants and used to retransform Tcs cells, no overnight grow out was required to obtain transformants, and they arose at a frequency of 2 x 10-7.
Plasmids pJU12, pJU13, and pJU16 were used in these experiments, and similar results were obtained with each one. We find that the frequency of transformation with heterologous DNA was ca. 102-fold lower than with homologous DNA. In the complementary control experiment, plasmid DNA derived from C. perfringens will transform restriction-positive E. coli cells at a frequency of 104-fold lower than homologous DNA (Table 2 ). There is therefore probably a restriction-modification system in the genus Clostridium that differs from that in E. coli K-12, accounting for the reciprocal barriers to transformation. perfringens-E. coli shuttle plasmids. The restriction maps given here were derived from the known restriction map and nucleotide sequence of pBR322 (12) and from the experiments shown in Fig. 1 Table 3 shows that chimeric plasmid pJU12 is as efficient, and possibly more efficient, than native plasmid pCW3 in the transformation of C. perfringens 11268 CDR autoplasts. 1 2 3 4 5 6 7 8 FIG. 4 . Restriction endonuclease digestions of plasmids containing C. perfringens tet genes. Lanes 1, bacteriophage lambda, HindIIl fragment sizes are given in caption to Fig. 1 Several of the transformants obtained from both experiments reported in Table 3 were isolated, and plasmid DNA was prepared from them. In all cases examined, the DNA obtained was identical to the transforming DNA.
Stabilities of native and chimeric vectors. We compared the frequencies of loss of plasmids pCW3 (native) and pJU12 (chimeric) in either L-phase variants or walled cells of strain 11268 CDR. The strains listed in Table 4 were carried for many generations under nonselective conditions for the plasmids. We have calculated the probability of plasmid loss per generation for each. The results (Table 4) show that there is little difference between the stabilities of plasmids pCW3 and pJU12 in L-phase variants or in walled cells. However, the curing rates from L-phase variants appear to be at least 10 times greater for both plasmids than for those from walled cells. Although it has not been tested directly, we believe that the Tcs clones scored in these experiments have been cured of the plasmids because the curing probabilities are too high to be easily accounted for by mutation. DISCUSSION We have constructed a series of plasmid vectors which can be selected in both E. coli and C. perfringens. These vectors were assembled in two steps. First, through a survey of C. perfringens strains that were likely to be carrying plasmids, we were able to identify, purify, and characterize three small cryptic plasmids. Each of these plasmids was cloned as a single fragment into the BamHI site of E. coli plasmid pBR322, thereby destroying by insertion the activity of the pBR322 tet gene. All three of these plasmids (pJU1, pJU3, and pJU5; Fig. 2 ) contain ori sequences that should be recognized in C. perfringens unless they have been disrupted by linearization for cloning. Each of these plasmids was stable in E. coli and conferred resistance to ampicillin on the bacterium.
The C. perfringens transformation procedure depends coli. This same conclusion can be drawn from experiments in which the celA and celB genes of Clostridium thermocellum were cloned to E. coli (4).
We used chimeric vectors pJU12, pJU13, and pJU16 purified from E. coli to transform L-phase variants of C. perfringens 11268 CDR. We did not find transformation of C. perfringens 11268 CDR L-phase variants with plasmids pJU7 or pJIU10 described in Fig. 2 . Both of these plasmids contain the C. perfringens ori sequence from plasmid pJU281. This may mean that this ori sequence has been disrupted in the construction of pJU1 or that the frequency of transformation is simply so low that we have not yet been able to detect transformants.
Evidence that restriction barriers exist between E. coli and C. perfringens is presented in Table 2 . Transformation a Values were determined by applying the equationf = e'", wheref is the fraction of cells containing a plasmid (Tc9), n is the number of generations sincef = 1, and P is the probability of loss per generation. n values, 12 to 16. The equation is valid when P is small. of C. perfringens with heterologous DNA is ca. 100-fold less successful than that with homologous DNA (see above), and, as shown in Table 2 , C. perfringens-derived DNA is 10,000-fold less effective at transforming E. coli than is identical DNA derived from E. coli. Differences in restriction patterns for some enzymes when E. coli-and C. perfringens-derived plasmid DNAs were studied support differential modification by the two organisms. MboI and EcoRII did not cut DNA derived from wild-type strains of E. coli because of modification but did cut the same sequences from C. perfringens.
The autoplast method of transforming C. perfringens 11268 CDR appears to be between 10l and 102 times more effective than the L-phase variant method when homologous DNAs are used. The two types of protoplasts are likely to be quite different because they are formed and propagated in different ways. Also, the frequency of transformation obtained does not vary linearly with DNA concentration (6) . If degradation of plasmid DNA during transformation or some other variable factor were the cause of this, it could also contribute to the observed differences in transformation frequencies obtained with the two types of cells. At present, the L-phase variant transformation procedure is indispensable because it alone yields C. perfringens transformants when using plasmid DNA derived from E. coli. We
have not yet been able to obtain transformants by using autoplasts and heterologous DNA. This is presumably because we cannot use an expression period in this procedure because autoplasts seem to divide very poorly in liquid medium (6) . We are currently modifying the autoplast procedure to allow both protoplast regeneration to walled cells and transformation with heterologous DNA.
It appears that, per plasmid DNA molecule, chimeric vector pJU12 and native plasmid pCW3 are equally competent in transforming autoplasts of C. perfringens 11268 CDR (Table 3) . This is surprising because pCW3 is a plasmid of more than 40 kb and suggests that polyethylene glycolmediated transformation of autoplasts of 11268 CDR has little plasmid size dependence. Plasmids like pJU12 are likely then to be useful for cloning large fragments of DNA, up to at least 30 kb, into C. perfringens.
Segregation of plasmid DNA is probably less precise during division of L-phase variants than in walled cells because the probability of loss of plasmid per generation from L-phase variants is 10-to 100-fold greater than that from walled cells ( 
